Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 3 (of 3 Records)

Query Trace: Epilepsy and CPS1[original query]
4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.
Epilepsy research 2014 Aug 108 (6): 1046-51.
Inoue Kazuyuki, Suzuki Eri, Takahashi Toshiki, Yamamoto Yoshiaki, Yazawa Rei, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Inoue Yushi, Tsuji Daiki, Hayashi Hideki, Itoh Kunihi
Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
Basic & clinical pharmacology & toxicology 2018 May .
Zhu Xu, Li Xinlin, Zhang Ti, Zhao Lim
CPS1 T1405N polymorphism, HDL cholesterol, homocysteine and renal function are risk factors of VPA induced hyperammonemia among epilepsy patients.
Epilepsy research 2019 May 154 139-143.
Chen Lanlan, Tian Qiuxiang, Zhang Miaoran, Chen Deyu, Gao Xue, Yang Hongqun, Li Haitao, Li Chengnan, Wen Jianping, Li Yulin, Tian Xin, Chen Pe
TOP